🔴 Noveris Health Sciences is trading 12% down; catalyst remains unclear

Noveris Health Sciences is trading at CA$0.07, down 11.76%, with no specific catalyst identified for the September 29 decline.

• The latest located company release was September 9’s annual-meeting results.
• The supplied market snapshot shows mixed, modest index moves and does not establish a broad-market explanation for the decline.
• No volume information was provided.